Sage Journals: Discover world-class research

1-10 of 10 results for Daclizumab beta

Sort by:

Relevance

Select allExport selected citations

Sort by:

Relevance

Open access

Research article

First published 2018-12

Efficacy of daclizumab beta versus intramuscular interferon beta-1a on disability progression across patient demographic and disease activity subgroups in DECIDE

Stanley Cohan, Ludwig Kappos, Gavin Giovannoni [...]

Multiple Sclerosis Journal

Open access

Research article

First published 2018-5

Improved cognitive outcomes in patients with relapsing–remitting multiple sclerosis treated with daclizumab beta: Results from the DECIDE study

Ralph HB Benedict, Stanley Cohan, Sharon G Lynch [...]

Multiple Sclerosis Journal

Retricted access

Research article

First published 2018-11

Circulating lymphocyte levels and relationship with infection status in patients with relapsing–remitting multiple sclerosis treated with daclizumab beta

Gavin Giovannoni, Heinz Wiendl, Benjamin Turner [...]

Multiple Sclerosis Journal

Open access

Research article

First published 2021

Safety and efficacy of daclizumab beta in patients with relapsing multiple sclerosis in a 5-year open-label study (EXTEND): final results following early termination

Ludwig Kappos, Stanley Cohan, Douglas L. Arnold [...]

Therapeutic Advances in Neurological Disorders

Retricted access

Research article

First published 2017-11

No evidence of disease activity in patients receiving daclizumab versus intramuscular interferon beta-1a for relapsing-remitting multiple sclerosis in the DECIDE study

Ludwig Kappos, Eva Havrdova, Gavin Giovannoni [...]

Multiple Sclerosis Journal

Retricted access

Review article

First published 2010-10

Current and Future Role of Interferon Beta in the Therapy of Multiple Sclerosis

Rachel A. Farrell, Gavin Giovannoni

Journal of Interferon & Cytokine Research

Retricted access

Research article

First published 2014-4

2014 Multiple Sclerosis Therapeutic Update

Bruce A. C. Cree

The Neurohospitalist

Retricted access

Review article

First published 2024-12

What is the evidence on immunomodulators and immunosuppressants for relapsing-remitting multiple sclerosis? – A Cochrane Review summary with commentary

Antimo Moretti

NeuroRehabilitation

Retricted access

Research article

First published 2011-12

Intermediate-affinity interleukin-2 receptor expression predicts CD56 bright natural killer cell expansion after daclizumab treatment in the CHOICE study of patients with multiple sclerosis

James P Sheridan, Ying Zhang, Katherine Riester [...]

Multiple Sclerosis Journal

Retricted access

Review article

First published 2023-5

Seizure risk in multiple sclerosis patients treated with disease-modifying therapy: A systematic review and network meta-analysis

Yew Li Dang, Vivien TY Yong, Sifat Sharmin [...]

Multiple Sclerosis Journal

Search results